Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time

Rhea-AI Summary

Senseonics Holdings, Inc. (SENS) plans to release its Q3 2023 financial results on November 9, 2023. The company is focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes. A conference call will be held to review the performance, which will be webcasted and archived on the company's website.

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its third quarter 2023 financial results after market close on Thursday, November 9, 2023.

Management will hold a conference call to review the Company’s third quarter 2023 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to “Investor Relations,” and then “Events & Publications,” and will be archived there for future reference. To listen to the conference call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061 (International), passcode 1409312, approximately ten to five minutes prior to start time.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems, Eversense®, Eversense® XL and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231030455705/en/

INVESTOR CONTACT

Philip Taylor

Gilmartin Group

415-937-5406

investors@senseonics.com

Source: Senseonics Holdings, Inc.

FAQ

When will Senseonics Holdings release its Q3 2023 financial results?

Senseonics Holdings plans to release its Q3 2023 financial results on November 9, 2023.

What is Senseonics Holdings focused on?

Senseonics Holdings is focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes.

Will there be a conference call to review the performance?

Yes, there will be a conference call to review Senseonics Holdings' Q3 2023 performance.

Where can I find the webcast of the conference call?

The webcast of the conference call will be available on Senseonics Holdings' website at www.senseonics.com under 'Investor Relations' and 'Events & Publications'.